Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

BACKGROUND: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation....

Descripción completa

Detalles Bibliográficos
Autores principales: Årdal, Christine, Baraldi, Enrico, Theuretzbacher, Ursula, Outterson, Kevin, Plahte, Jens, Ciabuschi, Francesco, Røttingen, John-Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885303/
https://www.ncbi.nlm.nih.gov/pubmed/29632669
http://dx.doi.org/10.1186/s40545-018-0135-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885303/
https://www.ncbi.nlm.nih.gov/pubmed/29632669
http://dx.doi.org/10.1186/s40545-018-0135-0

Ejemplares similares